Regenerative Medical Technology Group Inc.

Blue Horizon International AGHealthcare & BiotechnologyUnited States

64% matchPrivate

Blue Horizon International AG is a global healthcare consulting and innovation company that specializes in adult and pediatric stem cell-based therapies and regenerative medicine. The company focuses on scientific research, education, clinical care, and philanthropy, collaborating with international physicians, research institutions, and regulated facilities. It provides investigational cellular and exosome products evaluated through clinical studies conducted under institutional review board approvals.

BioStem Technologies, Inc. engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenerative therapies in the United States. It offers Vendaje, a structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje AC, a thicker structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje OPTIC, a structural tissue allograft used as a protective covering during the repair of ocular surfaces; American Amnion AC, a human connective tissue matrix for homologous use; and American Amnion, a human connective tissue matrix for homologous use. The company was formerly known as Caribbean International Holdings Inc. and changed its name to BioStem Technologies, Inc. in August 2014. BioStem Technologies, Inc. was incorporated in 2006 and is based in Fort Lauderdale, Florida.

An integrated regenerative medicine and longevity company focused on the research, manufacturing, and commercialization of regenerative health technologies, stem cell-derived products, wellness solutions, and advanced skincare.

Creative Medical Technology Holdings, Inc., a biotechnology firm based in Phoenix, Arizona, specializes in advancing adult stem cell treatments. The company's core focus spans several medical fields, including immunology, urology, orthopedics, and neurology. Among its therapeutic offerings are CaverStem, designed to address erectile dysfunction; FemCelz, which aims to restore genital sensitivity and alleviate dryness; StemSpine, developed to treat chronic lower back pain; ImmCelz, intended for stroke patients; and OvaStem, a solution for female infertility.

Zeo ScientifiX, Inc.ZEOX · BiotechDavie, United States

66% matchPublic

Zeo ScientifiX, Inc. is a clinical-stage biopharmaceutical company specializing in developing biological therapeutics aimed at treating degenerative diseases and fostering regenerative medicine. Its flagship investigational product, Zofin, is an acellular biologic therapy sourced from perinatal materials. This candidate is currently in Phase I/II clinical trials, evaluating its efficacy for COVID-19, chronic obstructive pulmonary disease (COPD), and knee osteoarthritis. The company's portfolio also includes Patient Pure X, an autologous, blood-derived biologic technology designed to enhance the body's natural capacity to reduce cellular inflammation and promote tissue healing. Furthermore, Zeo ScientifiX develops and distributes products containing its proprietary ingredients for topical aesthetic applications. These offerings include ZEO GROW X, a professional-grade formula delivering concentrated topical exosomes to support follicular function, as well as ZEO GROW BOOST and EXO FOLLICLE FUEL. Founded in 2011, the company was formerly known as Organicell Regenerative Medicine, Inc. before rebranding to Zeo ScientifiX, Inc. in February 2024. It is headquartered in Davie, Florida.

NovelStem International Corp. concentrates its efforts on pioneering and introducing diagnostic solutions for cancer treatment, specifically with the goal of mitigating chemotherapy resistance. The company, which commenced operations in 1993, was previously recognized as Hollywood Media Corp. before adopting its current name in September of 2018. Its corporate headquarters are situated in Boca Raton, Florida.